Nuveen Asset Management’s Sutro Biopharma STRO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $2.44M | Buy |
1,323,777
+124,154
| +10% | +$228K | ﹤0.01% | 2293 |
|
|
2024
Q3 | $4.15M | Buy |
1,199,623
+294,180
| +32% | +$1.02M | ﹤0.01% | 2075 |
|
|
2024
Q2 | $2.65M | Buy |
905,443
+567,815
| +168% | +$1.66M | ﹤0.01% | 2247 |
|
|
2024
Q1 | $1.91M | Buy |
337,628
+121,900
| +57% | +$689K | ﹤0.01% | 2426 |
|
|
2023
Q4 | $925K | Buy |
215,728
+3,583
| +2% | +$15.4K | ﹤0.01% | 2764 |
|
|
2023
Q3 | $736K | Sell |
212,145
-1,474
| -0.7% | -$5.12K | ﹤0.01% | 2700 |
|
|
2023
Q2 | $993K | Sell |
213,619
-24,842
| -10% | -$116K | ﹤0.01% | 2654 |
|
|
2023
Q1 | $1.1M | Buy |
238,461
+30,331
| +15% | +$140K | ﹤0.01% | 2577 |
|
|
2022
Q4 | $1.68M | Sell |
208,130
-22,474
| -10% | -$182K | ﹤0.01% | 2470 |
|
|
2022
Q3 | $1.28M | Sell |
230,604
-868
| -0.4% | -$4.82K | ﹤0.01% | 2635 |
|
|
2022
Q2 | $1.21M | Buy |
231,472
+45,340
| +24% | +$236K | ﹤0.01% | 2701 |
|
|
2022
Q1 | $1.48M | Buy |
186,132
+3,932
| +2% | +$31.3K | ﹤0.01% | 2651 |
|
|
2021
Q4 | $2.71M | Sell |
182,200
-176,061
| -49% | -$2.62M | ﹤0.01% | 2413 |
|
|
2021
Q3 | $6.77M | Sell |
358,261
-47,934
| -12% | -$905K | ﹤0.01% | 2054 |
|
|
2021
Q2 | $7.55M | Buy |
406,195
+20,967
| +5% | +$390K | ﹤0.01% | 2026 |
|
|
2021
Q1 | $8.77M | Buy |
385,228
+120,905
| +46% | +$2.75M | ﹤0.01% | 1874 |
|
|
2020
Q4 | $5.74M | Buy |
264,323
+154,882
| +142% | +$3.36M | ﹤0.01% | 1997 |
|
|
2020
Q3 | $1.1M | Buy |
109,441
+58,706
| +116% | +$590K | ﹤0.01% | 2644 |
|
|
2020
Q2 | $393K | Buy |
50,735
+11,294
| +29% | +$87.5K | ﹤0.01% | 2981 |
|
|
2020
Q1 | $403K | Buy |
39,441
+12,202
| +45% | +$125K | ﹤0.01% | 2842 |
|
|
2019
Q4 | $300K | Sell |
27,239
-995
| -4% | -$11K | ﹤0.01% | 3012 |
|
|
2019
Q3 | $257K | Buy |
28,234
+12,279
| +77% | +$112K | ﹤0.01% | 3079 |
|
|
2019
Q2 | $182K | Buy |
+15,955
| New | +$182K | ﹤0.01% | 3172 |
|